• Cannabis Drug Reduces Drop Seizures in Severe Epilepsy

    1 month ago - By Medscape

    Phase 3 data add rigorous evidence that a highly purified form of cannabidiol significantly reduces drop seizures in Lennox-Gastaut syndrome; FDA action expected in June.
    Medscape Medical News
    Read more ...

     

  • Pfizer announces Phase 3 study results of LYRICA Oral Solution CV for pediatric epilepsy patients

    1 month ago - By News Medical

    Pfizer Inc. announced today positive top-line results of a Phase 3 study examining the use of LYRICA® Oral Solution CV as adjunctive therapy for partial onset seizures in pediatric epilepsy patients one month to less than four years of age.
    Read more ...